Patients with IPF show higher percentages of CCR2+ CD4+ T cells expressing Foxp3+ CD25+ within bronchoalveolar lavage fluid [149], suggesting immune regulatory functions of these leukocytes that could attenuate lung inflammation and fibrosis. This evidence concerns the gene CD4 and idiopathic interstitial pneumonia.